Contraception
Volume 81, Issue 1 , Pages 41-48, January 2010

The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol☆

  • Robin Kroll

      Affiliations

    • Women's Clinical Research Center, Seattle, WA 98105, USA
    • ,
  • Kathleen Z. Reape

      Affiliations

    • Duramed Research, Inc., Bala Cynwyd, PA 19004, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 610 747 2600.
    • ,
  • Marya Margolis

      Affiliations

    • Duramed Research, Inc., Bala Cynwyd, PA 19004, USA

Received 20 March 2009; received in revised form 7 July 2009; accepted 9 July 2009. published online 04 September 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ This study was funded by Duramed Pharmaceuticals, Inc. Drs. Reape and Margolis are full-time employees of Duramed Research, Inc.

PII: S0010-7824(09)00348-5

doi:10.1016/j.contraception.2009.07.003

Contraception
Volume 81, Issue 1 , Pages 41-48, January 2010

Article Tools

* Image Usage & Resolution